CellaVision AB (publ) (STO: CEVI)
Sweden
· Delayed Price · Currency is SEK 260.00
-3.50 (-1.33%)
Sep 2, 2024, 9:12 AM CET
CellaVision AB Revenue
CellaVision AB had revenue of 187.79M SEK in the quarter ending June 30, 2024, with 10.68% growth. This brings the company's revenue in the last twelve months to 726.40M, up 20.64% year-over-year. In the year 2023, CellaVision AB had annual revenue of 677.29M with 5.94% growth.
Revenue (ttm)
726.40M
Revenue Growth
+20.64%
P/S Ratio
8.65
Revenue / Employee
3.29M
Employees
221
Market Cap
6.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | 461.77M | 96.96M | 26.58% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 520.76B |
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.04B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |